University of Pittsburgh-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2019

  1. Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3

    Cell, Vol. 176, Núm. 1-2, pp. 334-347.e12

  2. Metabolic consequences of T-cell costimulation in anticancer immunity

    Cancer Immunology Research, Vol. 7, Núm. 10, pp. 1664-1669

2016

  1. Emerging opportunities and challenges in cancer immunotherapy

    Clinical Cancer Research, Vol. 22, Núm. 8, pp. 1845-1855

2014

  1. Classification of current anticancer immunotherapies

    Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508